203 results
Page 5 of 11
424B5
9nbhciaaos5l mld51
14 Jul 20
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
zgdupoy yoyepcvl26f
29 May 20
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology
4:15pm
8-K
EX-99.1
jkqyb7330ya 1u4a
15 May 20
Bio-path Holdings Reports First Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
5dlt3ioc7 nx
27 Apr 20
Bio-Path Holdings Presents at 2020 American Association for Cancer Research Annual Meeting
4:31pm
8-K
EX-99.1
6flq1zja
14 Apr 20
Bio-Path Holdings to Present at the 2020 American Association for Cancer Research Annual Meeting
12:00am
8-K
EX-99.1
ni4uwfjj5wln5 8gk
6 Mar 20
Bio-path Holdings Reports Full Year 2019 Financial Results
7:10am
8-K
EX-99.1
4dysut
8 Jan 20
Bio-Path Holdings Provides Clinical Update and 2020 Business Outlook
4:30pm
8-K
EX-99.1
pgd2qyq
26 Nov 19
Bio-path Holdings Announces Successful Completion of Safety Testing In Stage 2 of Phase 2 Clinical Trial In Acute Myeloid Leukemia
4:30pm
8-K
umwhut
26 Nov 19
Bio-path Holdings Announces Successful Completion of Safety Testing In Stage 2 of Phase 2 Clinical Trial In Acute Myeloid Leukemia
4:30pm
424B5
v1affdblasdcz
22 Nov 19
Prospectus supplement for primary offering
7:41pm
8-K
EX-10.1
km6jc fwp
22 Nov 19
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-99.1
wpnh6urw6xmtz83
21 Nov 19
Bio-path Holdings Announces Clearance of Investigational New Drug Application for BP1002
8:20am
8-K
EX-99.1
77798v
15 Nov 19
Bio-path Holdings Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
rr8 meiwux
26 Aug 19
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
9:33pm
8-K
EX-99.1
thq0oe8
15 Aug 19
Bio-path Holdings Reports Second Quarter 2019 Financial Results
7:05am
424B5
9kud knqvqo5
6 Jun 19
Prospectus supplement for primary offering
5:06pm